Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christel Zufferey

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Tuberculosis (Edinburgh, Scotland)|April 4, 2015
The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assaysVanessa Clifford, Christel Zufferey, Susie Germano, et al.
The Journal of Infection|May 10, 2017
Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosisVanessa Clifford, Marc Tebruegge, Christel Zufferey, et al.
Tuberculosis (Edinburgh, Scotland)|February 4, 2019
Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence settingVanessa Clifford, Marc Tebruegge, Christel Zufferey, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2015
Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active TuberculosisMarc Tebruegge, Binita Dutta, Susan Donath, et al.
Inflammatory Bowel Diseases|February 10, 2011
IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivoJonas Mudter, Jingling Yu, Christel Zufferey, et al.
Frontiers in Immunology|April 27, 2019
Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept StudyMarc Tebruegge, Nicole Ritz, Susan Donath, et al.
Allergy|July 26, 2021
Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trialLaure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
BMJ Open|December 18, 2019
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality settingNicole L Messina, Kaya Gardiner, Susan Donath, et al.
The Journal of Infectious Diseases|June 19, 2021
Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled TrialNicole L Messina, Laure F Pittet, Kaya Gardiner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 14, 2024
Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled TrialNicole L Messina, Kaya Gardiner, Laure F Pittet, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Tuberculosis (Edinburgh, Scotland)|April 4, 2015
The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assaysVanessa Clifford, Christel Zufferey, Susie Germano, et al.
The Journal of Infection|May 10, 2017
Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosisVanessa Clifford, Marc Tebruegge, Christel Zufferey, et al.
Tuberculosis (Edinburgh, Scotland)|February 4, 2019
Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence settingVanessa Clifford, Marc Tebruegge, Christel Zufferey, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2015
Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active TuberculosisMarc Tebruegge, Binita Dutta, Susan Donath, et al.
Inflammatory Bowel Diseases|February 10, 2011
IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivoJonas Mudter, Jingling Yu, Christel Zufferey, et al.
Frontiers in Immunology|April 27, 2019
Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept StudyMarc Tebruegge, Nicole Ritz, Susan Donath, et al.
Allergy|July 26, 2021
Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trialLaure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
BMJ Open|December 18, 2019
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality settingNicole L Messina, Kaya Gardiner, Susan Donath, et al.
The Journal of Infectious Diseases|June 19, 2021
Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled TrialNicole L Messina, Laure F Pittet, Kaya Gardiner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 14, 2024
Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled TrialNicole L Messina, Kaya Gardiner, Laure F Pittet, et al.
Pageof 2